Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
05/2001
05/31/2001CA2370322A1 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use
05/30/2001EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods
05/30/2001EP1102781A1 New cofactors for methyltransferases
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001EP0914334B1 Process and intermediates for the synthesis of lhrh antagonists
05/30/2001EP0879243B1 (n)-(s)-1-phenyl-1-alkanamide (n)-(3,3-dimethylbutyl)-l-aspartyl-d-alpha aminoalkanoic acid for use as a sweetener
05/30/2001EP0621788B1 Hemoregulatory peptides
05/30/2001CN1296951A Affinity preparing process of albumin and antibody
05/29/2001USRE37194 High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay
05/29/2001US6239273 Printing molecular library arrays
05/29/2001US6239261 Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof
05/29/2001US6238884 End selection in directed evolution
05/29/2001US6238864 Simple, sensitive in vitro detection of binding of analyte to capturing agent positioned on dna through production of reporter rna; high molecular weight analytes; can be automated
05/29/2001US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins
05/29/2001US6238664 Process for stabilizing proteins
05/29/2001US6238624 A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats.
05/29/2001CA2031803C Improvements in or relating to glycopeptide deriveratives
05/25/2001WO2001037191A2 Method for manipulating protein or dna sequence data (in order to generate complementary peptide ligands)
05/25/2001WO2001036450A1 S-allylmercaptoglutathione and uses thereof
05/25/2001WO2001036449A1 Multi-compartment electrophoresis
05/25/2001WO2001036006A1 Opioid metallopeptide compositions and methods
05/25/2001WO2001036001A2 Interferon gamma conjugates
05/25/2001CA2391969A1 S-allylmercaptoglutathione and uses thereof
05/25/2001CA2390292A1 Interferon gamma conjugates
05/24/2001US20010001657 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
05/23/2001EP1100919A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
05/23/2001EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/23/2001EP1100812A2 Resin derivatization method and uses thereof
05/23/2001EP1100782A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001EP0877761B1 Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof
05/23/2001CN1066154C Process for preparing refined vitelline antibody
05/22/2001US6236946 Nuclear receptor ligands and ligand binding domains
05/22/2001US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides
05/22/2001US6235710 Spray dried erythropoietin
05/17/2001WO2001034765A1 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices
05/17/2001WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
05/17/2001WO2001034635A2 Methods and compositions for peptide synthesis
05/17/2001WO2001018627A3 Method and apparatus for computer automated detection of protein and nucleic acid targets of a chemical compound
05/17/2001WO2001010890A3 Process of synthesis of fluorescent protease substrates
05/17/2001WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
05/17/2001DE19952956A1 Verfahren zur Verbindung von molekularen Substanzen A method for connection of molecular substances
05/17/2001DE19952955A1 Verfahren zur Charakterisierung und zur Auftrennung von molekularen Assoziaten A method for characterization and for the separation of molecular associates
05/17/2001CA2378086A1 Methods and compositions for peptide synthesis
05/16/2001EP1099756A1 Labeled complex, process for producing the same and process for utilizing the same
05/16/2001EP1099708A1 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
05/16/2001EP1098907A1 Clarification of protein precipitate suspensions using anionic polymeric flocculants
05/16/2001EP1098660A1 Encapsulation of water soluble peptides
05/16/2001CN1295616A Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them
05/16/2001CN1295580A Method for producing mouse and haman endogenous vascular formation inhibition factor
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1295080A Method of extracting phycocyanin from spirulina
05/16/2001CN1065864C Aylucone isoflavone enriched regetable protein whey, whey protein, and process for producing same
05/15/2001US6232085 Method for determining conditions that stabilize proteins
05/15/2001US6231862 Purified new epididymal forward motility protein and a process for the isolation of the said epididymal forward motility protein useful as a fertility prometer/blocker
05/15/2001US6231851 Methods and compositions for the dry powder formulation of interferons
05/15/2001CA2195975C An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
05/15/2001CA2078858C Expression of heterologous protein in yeast
05/10/2001WO2001033438A2 Method for generating information related to the molecular structure of a biomolecule
05/10/2001WO2001032783A1 Water-soluble rhodamine dyes and conjugates thereof
05/10/2001WO2001032694A2 Method for characterising and separating molecular associates
05/10/2001WO2001032691A1 Hcv ns3 protease inhibitors
05/10/2001WO2001032684A2 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww
05/10/2001WO2001007469A3 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs
05/10/2001WO2000061635A3 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
05/10/2001CA2389543A1 Hcv ns3 protease inhibitors
05/09/2001EP1097995A1 Process for purification of human alpha interferon produced in yeast cells
05/09/2001EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor
05/09/2001EP1097943A1 Process for the preparation of hyperpolymers of haemoglobin with uniform molecular weight
05/09/2001EP1097383A1 Device and method for the determination of protein domain boundaries
05/09/2001EP1097171A1 Method for purifying hemoglobin
05/09/2001EP1097164A1 Processes for coupling amino acids using bis-(trichloromethyl) carbonate
05/09/2001CN1294596A Method for reducing immunogenicity of proteins
05/09/2001CN1294595A Hydrophobically-modified protein compsns, and methods
05/09/2001CN1294134A Polypeptide structure of shark liver for preventing and curing hepatism and its purifying process
05/09/2001CN1294000A Process for preparing uropoly acid-peptide composition
05/09/2001CN1065568C Bacteriocins from streptococcus thermophilus
05/09/2001CN1065538C Antibiotic stalobacins
05/08/2001US6229055 Synthesis of fluorinated xanthene derivatives
05/08/2001US6228994 Labeled protein and its producing method, labeling compound to be used in the method, and method for analyzing function of genes
05/08/2001US6228988 Synthesis of hydroxamic acid derivatives
05/08/2001US6228613 Stable factor VIII/von Willebrand factor complex
05/08/2001US6228374 Polypeptides and immunology
05/03/2001WO2001031325A1 Method for separating a chemical or biological compound in a mixture of similar compounds by diffusion in a medium such as a gel
05/03/2001WO2001031006A2 Serum amyloid a isoform from colostrum
05/03/2001WO2001030856A1 Molecularly imprinted polymers produced by template polymerisation
05/03/2001WO2001030807A1 Process for the preparation of a dipeptide and intermediate product in such a process
05/03/2001WO2001030805A1 Silicone liquids as temperature regulating media for processes involving microwave facilitated transformations
05/03/2001WO2001030804A2 Salt form of a conjugate useful in the treatment of prostate cancer
05/03/2001US20010000807 Method for prediction of binding targets and the design of ligands
05/03/2001DE19952160A1 Verfahren, Vorrichtung und farbstoffmarkiertes Peptid zum Nachweis eines Moleküls, sowie Verfahren zur Herstellung eines farbstoffmarkierten Peptids und dessen Verwendung A method, apparatus and dye-labeled peptide for the detection of a molecule, and to methods for preparing a dye-labeled peptide and use thereof
05/03/2001CA2389024A1 Process for the preparation of a dipeptide and intermediate product in such a process
05/03/2001CA2388130A1 Molecularly imprinted polymers produced by template polymerisation
05/03/2001CA2387907A1 Serum amyloid a isoform from colostrum
05/03/2001CA2387901A1 Salt form of a conjugate useful in the treatment of prostate cancer
05/02/2001EP1096257A2 Method, device and dye labelled peptide for the detection of molecules
05/02/2001EP1095272A1 Determination of ligands for proteins
05/02/2001EP1095141A2 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5
05/02/2001EP1095134A1 Method to prepare c-terminal modified peptides
05/02/2001EP1095058A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same